Tag Archives: NASDAQ:NUVA

Cantor Fitzgerald Remains a Hold on NuVasive (NUVA)

In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on NuVasive (NUVA – Research Report), with a price target of $85.00. The company’s shares closed last Monday at $74.83. According to TipRanks.com, Bijou has currently

Morgan Stanley Keeps Their Hold Rating on NuVasive (NUVA)

In a report released today, Jonathan Demchick from Morgan Stanley maintained a Hold rating on NuVasive (NUVA – Research Report), with a price target of $82.00. The company’s shares closed last Monday at $76.80, close to its 52-week high of

NuVasive (NUVA) Receives a Hold from Needham

In a report released today, Michael Matson from Needham maintained a Hold rating on NuVasive (NUVA – Research Report). The company’s shares closed last Monday at $66.46, close to its 52-week high of $69.10. According to TipRanks.com, Matson is a

Needham Keeps a Hold Rating on NuVasive (NUVA)

In a report released today, Michael Matson from Needham maintained a Hold rating on NuVasive (NUVA – Research Report). The company’s shares opened today at $65.84. According to TipRanks.com, Matson is a 5-star analyst with an average return of 7.8%

NuVasive (NUVA) Gets a Buy Rating from BTIG

BTIG analyst Ryan Zimmerman maintained a Buy rating on NuVasive (NUVA – Research Report) on June 27 and set a price target of $65. The company’s shares closed on Friday at $58.54. According to TipRanks.com, Zimmerman is a top 100

NuVasive (NUVA) Gets a Hold Rating from Cantor Fitzgerald

Cantor Fitzgerald analyst Craig Bijou maintained a Hold rating on NuVasive (NUVA – Research Report) yesterday and set a price target of $61. The company’s shares closed yesterday at $60.60. Bijou noted: “: We maintain our Neutral rating on NUVA,